Gallus gallus isolate bGalGal1 chromosome 28, bGalGal1.mat.broiler.GRCg7b, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Gallus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM028509.1.\nAssembly name: bGalGal1.mat.broiler.GRCg7b\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/01/19. The original whole-genome shotgun project has the\naccession JAENSK000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 22-JUL-2020\nAssembly Method :: TrioCanu v. 1.8; purge_dups v. 1.0.0;\n Scaff 10x v. 4.1.0; Bionano solve v.\n 3.2.1_04122018; Salsa2 HiC v. 2.2; Arrow\n polishing and gap filling v.\n SMRTLink7.0.1; Freebayes v. 1.3.1; gEVAL\n manual curation v. 2020-07-22; VGP trio\n assembly pipeline v. 1.6\nAssembly Name :: bGalGal1.mat.broiler.GRCg7b\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 102.01x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Gallus gallus Annotation Release 106\nAnnotation Version :: 106\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC121107762, transcript variant X2
uncharacterized LOC121107762, transcript variant X1
uncharacterized LOC121107762, transcript variant X4
uncharacterized LOC121107762, transcript variant X3
uncharacterized LOC121107716, transcript variant X1
uncharacterized LOC121107716, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC101748894, transcript variant X4
COORDINATES: cap analysis [ECO:0007248] and polyA evidence [ECO:0006239]
uncharacterized LOC101748894, transcript variant X7
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC101748894, transcript variant X8
uncharacterized LOC101748894, transcript variant X10
uncharacterized LOC101748894, transcript variant X6
uncharacterized LOC101748894, transcript variant X9
uncharacterized LOC101748894, transcript variant X11
uncharacterized LOC101748894, transcript variant X3
uncharacterized LOC101748894, transcript variant X5
uncharacterized protein LOC101748894 isoform X3
uncharacterized LOC101748894, transcript variant X2
uncharacterized protein LOC101748894 isoform X2
uncharacterized LOC101748894, transcript variant X1
uncharacterized protein LOC101748894 isoform X1
uncharacterized LOC112531437, transcript variant X1
uncharacterized LOC112531437, transcript variant X3
uncharacterized LOC112531437, transcript variant X2
uncharacterized LOC112530360, transcript variant X2
uncharacterized LOC112530360, transcript variant X3
uncharacterized LOC112530360, transcript variant X1
major vault protein; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
major vault protein, transcript variant X1
major vault protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 1
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 2
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 3
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 4
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 5
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 6
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 7
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 8
propagated from UniProtKB/Swiss-Prot (Q5ZMI4.1); Region: MVP 9
G2/M phase-specific E3 ubiquitin-protein ligase-like
PHD finger protein 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
ceramide synthase 4, transcript variant X1
ceramide synthase 4, transcript variant X2
ceramide synthase 4, transcript variant X7
ceramide synthase 4, transcript variant X3
ceramide synthase 4, transcript variant X5
ceramide synthase 4, transcript variant X4
ceramide synthase 4, transcript variant X6
ceramide synthase 4, transcript variant X8
ceramide synthase 4, transcript variant X9
uncharacterized LOC100859213, transcript variant X1
uncharacterized LOC100859213, transcript variant X2
endogenous retrovirus group K member 18 Pol protein-like, transcript variant X2
endogenous retrovirus group K member 18 Pol protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC101749435, transcript variant X2
uncharacterized LOC101749435, transcript variant X1
uncharacterized LOC420052; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC121107727, transcript variant X2
uncharacterized LOC121107727, transcript variant X1
translocase of inner mitochondrial membrane 44; Derived by automated computational analysis using gene prediction method: BestRefSeq.
translocase of inner mitochondrial membrane 44
mitochondrial import inner membrane translocase subunit TIM44
heterogeneous nuclear ribonucleoprotein M; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
heterogeneous nuclear ribonucleoprotein M, transcript variant X7
heterogeneous nuclear ribonucleoprotein M, transcript variant X6
heterogeneous nuclear ribonucleoprotein M, transcript variant X5
heterogeneous nuclear ribonucleoprotein M
heterogeneous nuclear ribonucleoprotein M, transcript variant X3
heterogeneous nuclear ribonucleoprotein M, transcript variant X2
heterogeneous nuclear ribonucleoprotein M, transcript variant X10
heterogeneous nuclear ribonucleoprotein M, transcript variant X4
heterogeneous nuclear ribonucleoprotein M, transcript variant X9
heterogeneous nuclear ribonucleoprotein M, transcript variant X8
heterogeneous nuclear ribonucleoprotein M, transcript variant X1
heterogeneous nuclear ribonucleoprotein M isoform X3
heterogeneous nuclear ribonucleoprotein M isoform X2
heterogeneous nuclear ribonucleoprotein M isoform X10
heterogeneous nuclear ribonucleoprotein M isoform X4
heterogeneous nuclear ribonucleoprotein M isoform X9
heterogeneous nuclear ribonucleoprotein M isoform X8
heterogeneous nuclear ribonucleoprotein M isoform X1
heterogeneous nuclear ribonucleoprotein M isoform X7
heterogeneous nuclear ribonucleoprotein M isoform X6
heterogeneous nuclear ribonucleoprotein M isoform X5
ceramide synthase 4-like, transcript variant X1
ceramide synthase 4-like, transcript variant X2
kelch-like protein 23-like, transcript variant X2
kelch-like protein 23-like, transcript variant X1
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated; Derived by automated computational analysis using gene prediction method: BestRefSeq.
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant 2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001389401.1
annotated by transcript or proteomic data
The RefSeq transcript has 9 substitutions, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated, transcript variant 1
isoform 2 is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
U6 snRNA-associated Sm-like protein LSm7 isoform 2
isoform 1 is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
U6 snRNA-associated Sm-like protein LSm7 isoform 1
signal peptide peptidase like 2C; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
signal peptide peptidase like 2C, transcript variant X1
signal peptide peptidase-like 2B precursor
COORDINATES: ab initio prediction:SignalP:4.0
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q5F383.1); glycosylation site
propagated from UniProtKB/Swiss-Prot (Q5F383.1); transmembrane region
propagated from UniProtKB/Swiss-Prot (Q5F383.1); Region: PAL
propagated from UniProtKB/Swiss-Prot (Q5F383.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
signal peptide peptidase-like 2B isoform X1
transmembrane protease, serine 9, transcript variant X1
transmembrane protease, serine 9, transcript variant X2
transmembrane protease serine 9 isoform X1
transmembrane protease serine 9 isoform X2
translocase of inner mitochondrial membrane 13; Derived by automated computational analysis using gene prediction method: BestRefSeq.
translocase of inner mitochondrial membrane 13
mitochondrial import inner membrane translocase subunit Tim13
lamin B2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
propagated from UniProtKB/Swiss-Prot (P14732.1)
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Head
N-acetylserine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P14732.1); acetylation site
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Coil 1A
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Coil 1B
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Coil 2
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Tail
propagated from UniProtKB/Swiss-Prot (P14732.1); Region: Nuclear localization signal. /evidence=ECO:0000255
Cysteine methyl ester. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P14732.1); methylation site
ribosomal protein L36; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ribosomal protein L36, transcript variant X1
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X5
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X2
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X6
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X3
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X4
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X7
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6, transcript variant X1
excitatory amino acid transporter 4 isoform X1
excitatory amino acid transporter 4 isoform X2
RAN binding protein 3, transcript variant X1
RAN binding protein 3, transcript variant X2
RAN binding protein 3, transcript variant X3
RAN binding protein 3, transcript variant X4
RAN binding protein 3, transcript variant X5
RAN binding protein 3, transcript variant X7
RAN binding protein 3, transcript variant X8
RAN binding protein 3, transcript variant X10
RAN binding protein 3, transcript variant X6
RAN binding protein 3, transcript variant X9
platelet glycoprotein Ib alpha chain-like
kelch like family member 33, transcript variant X3
kelch like family member 33, transcript variant X2
kelch like family member 33, transcript variant X1
NADH:ubiquinone oxidoreductase subunit A11, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 isoform X1
platelet glycoprotein Ib alpha chain isoform X1
butyrophilin subfamily 1 member A1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
butyrophilin subfamily 1 member A1, transcript variant X3
butyrophilin subfamily 1 member A1, transcript variant X1
butyrophilin subfamily 1 member A1, transcript variant X2
butyrophilin subfamily 1 member A1 isoform X3
butyrophilin subfamily 1 member A1 isoform X1
butyrophilin subfamily 1 member A1 isoform X2
butyrophilin subfamily 1 member A1 precursor
membrane associated ring-CH-type finger 2, transcript variant X1
membrane associated ring-CH-type finger 2, transcript variant X2
membrane associated ring-CH-type finger 2, transcript variant X3
RAB11B, member RAS oncogene family; Derived by automated computational analysis using gene prediction method: BestRefSeq.
KN motif and ankyrin repeat domains 3, transcript variant X2
KN motif and ankyrin repeat domains 3, transcript variant X1
KN motif and ankyrin repeat domain-containing protein 3 isoform X2
KN motif and ankyrin repeat domain-containing protein 3 isoform X1
KN motif and ankyrin repeat domains 3, transcript variant X4
KN motif and ankyrin repeat domains 3, transcript variant X3
KN motif and ankyrin repeat domain-containing protein 3 isoform X3
ribosomal protein S28; Derived by automated computational analysis using gene prediction method: BestRefSeq.
NADH:ubiquinone oxidoreductase subunit A7
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7
CD320 molecule; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
isoform 2 precursor is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 1 precursor is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
potassium voltage-gated channel subfamily V member 2-like
potassium voltage-gated channel subfamily V member 2
anti-dorsalizing morphogenetic protein; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_204822.2
The RefSeq transcript has 14 substitutions, 1 frameshift compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_990153.1
The RefSeq protein has 1 frameshift compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
anti-dorsalizing morphogenetic protein precursor
DNA polymerase epsilon 4, accessory subunit, transcript variant X2
DNA polymerase epsilon 4, accessory subunit, transcript variant X1
DNA polymerase epsilon 4, accessory subunit, transcript variant X3
DNA polymerase epsilon subunit 4 isoform X2
DNA polymerase epsilon subunit 4 isoform X1
DNA polymerase epsilon subunit 4 isoform X3
PML-RARA regulated adaptor molecule 1, transcript variant X1
PML-RARA regulated adaptor molecule 1, transcript variant X2
PML-RARA-regulated adapter molecule 1 isoform X1
PML-RARA-regulated adapter molecule 1 isoform X2
excitatory amino acid transporter 5-like, transcript variant X1
excitatory amino acid transporter 5-like, transcript variant X2
excitatory amino acid transporter 5-like isoform X2
excitatory amino acid transporter 5-like isoform X1
ELAV like RNA binding protein 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ELAV like RNA binding protein 1, transcript variant X5
ELAV like RNA binding protein 1, transcript variant X3
ELAV like RNA binding protein 1, transcript variant X1
ELAV like RNA binding protein 1, transcript variant X6
ELAV like RNA binding protein 1, transcript variant X4
ELAV like RNA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, and 96% coverage of the annotated genomic feature by RNAseq alignments
megakaryocyte-associated tyrosine kinase, transcript variant X2
megakaryocyte-associated tyrosine kinase, transcript variant X5
megakaryocyte-associated tyrosine kinase, transcript variant X3
megakaryocyte-associated tyrosine kinase, transcript variant X4
megakaryocyte-associated tyrosine kinase, transcript variant X1
megakaryocyte-associated tyrosine-protein kinase isoform X1
megakaryocyte-associated tyrosine-protein kinase isoform X2
cRax1; cRaxL; RAX; RAXL; Rx-like; RX1; RX2
retina and anterior neural fold homeobox 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
retina and anterior neural fold homeobox 2, transcript variant X1
retina and anterior neural fold homeobox 2
propagated from UniProtKB/Swiss-Prot (Q9PVY0.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (Q9PVY0.1); Region: OAR. /evidence=ECO:0000255|PROSITE-ProRule:PRU00138
propagated from UniProtKB/Swiss-Prot (Q9PVY0.1); Region: Nuclear localization signal. /evidence=ECO:0000255
paracaspase 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001031574.2
The RefSeq transcript has 22 substitutions, 2 frameshifts, 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001026745.1
The RefSeq protein has 4 substitutions, 2 frameshifts compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
39S ribosomal protein L54, mitochondrial
amyloid beta (A4) precursor protein-binding, family A, member 3
amyloid-beta A4 precursor protein-binding family A member 3
tight junction protein 3, transcript variant X3
tight junction protein 3, transcript variant X2
tight junction protein 3, transcript variant X1
tight junction protein 3, transcript variant X6
tight junction protein 3, transcript variant X5
tight junction protein 3, transcript variant X4
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant X3
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant X1
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant X5
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant X2
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma, transcript variant X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X1
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X4
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma
phosphatidylinositol 4-phosphate 5-kinase type-1 gamma isoform X3
thromboxane A2 receptor, transcript variant X2
thromboxane A2 receptor, transcript variant X1
thromboxane A2 receptor, transcript variant X3
thromboxane A2 receptor, transcript variant X4
GIPC PDZ domain containing family member 3
high mobility group 20B, transcript variant X3
high mobility group 20B, transcript variant X4
high mobility group 20B, transcript variant X2
high mobility group 20B, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related isoform X1
major facilitator superfamily domain containing 12, transcript variant X1
major facilitator superfamily domain containing 12, transcript variant X2
major facilitator superfamily domain-containing protein 12 isoform X1
major facilitator superfamily domain-containing protein 12 isoform X2
GRAM domain-containing protein 3-like, transcript variant X1
GRAM domain-containing protein 2A-like isoform X1
GRAM domain-containing protein 3-like, transcript variant X4
GRAM domain-containing protein 3-like, transcript variant X2
GRAM domain-containing protein 3-like, transcript variant X3
GRAM domain-containing protein 2B-like isoform X2
chromosome 19 open reading frame 71, transcript variant X1
uncharacterized protein C19orf71 homolog
fizzy/cell division cycle 20 related 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
fizzy/cell division cycle 20 related 1, transcript variant X1
fizzy/cell division cycle 20 related 1, transcript variant X3
fizzy/cell division cycle 20 related 1, transcript variant X2
fizzy-related protein homolog isoform X1
putative nuclease HARBI1-like, transcript variant X2
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 isoform X2
putative nuclease HARBI1-like, transcript variant X1
protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 isoform X1
deoxyhypusine hydroxylase/monooxygenase; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
deoxyhypusine hydroxylase/monooxygenase, transcript variant X2
deoxyhypusine hydroxylase/monooxygenase, transcript variant X1
propagated from UniProtKB/Swiss-Prot (Q5ZIP3.1); Region: HEAT-like PBS-type 1
propagated from UniProtKB/Swiss-Prot (Q5ZIP3.1); Region: HEAT-like PBS-type 2
propagated from UniProtKB/Swiss-Prot (Q5ZIP3.1); Region: HEAT-like PBS-type 3
propagated from UniProtKB/Swiss-Prot (Q5ZIP3.1); Region: HEAT-like PBS-type 4
propagated from UniProtKB/Swiss-Prot (Q5ZIP3.1); Region: HEAT-like PBS-type 5
uncharacterized LOC101749344, transcript variant X2
uncharacterized LOC101749344, transcript variant X3
uncharacterized LOC101749344, transcript variant X1
small integral membrane protein 24 isoform X1
uncharacterized LOC121107733, transcript variant X2
uncharacterized LOC121107733, transcript variant X1
uncharacterized protein LOC121107733 isoform X2
uncharacterized protein LOC121107733 isoform X1
nuclear factor I C; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
nuclear factor I C, transcript variant X6
nuclear factor I C, transcript variant X5
nuclear factor I C, transcript variant X4
nuclear factor I C, transcript variant X3
nuclear factor I C, transcript variant X2
nuclear factor I C, transcript variant X1
nuclear factor I C, transcript variant 7
nuclear factor I C, transcript variant 6
nuclear factor I C, transcript variant 4
nuclear factor I C, transcript variant 3
nuclear factor I C, transcript variant 5
nuclear factor I C, transcript variant 2
nuclear factor I C, transcript variant 1
isoform 4 is encoded by transcript variant 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (P17926.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (P17926.1); Region: 9aaTAD. /evidence=ECO:0000250|UniProtKB:P08651
isoform 7 is encoded by transcript variant 7; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 3 is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 6 is encoded by transcript variant 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
isoform 5 is encoded by transcript variant 5; Derived by automated computational analysis using gene prediction method: BestRefSeq.
unc-13 homolog A, transcript variant X10
unc-13 homolog A, transcript variant X11
unc-13 homolog A, transcript variant X13
unc-13 homolog A, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
WAS/WASL-interacting protein family member 3-like
phospholipid phosphatase 2, transcript variant X1
transducin-like enhancer protein 1-like, transcript variant X3
transducin-like enhancer protein 1-like, transcript variant X1
transducin-like enhancer protein 1-like, transcript variant X2
transducin-like enhancer protein 1-like, transcript variant X4
transducin-like enhancer protein 1-like, transcript variant X5
transducin-like enhancer protein 1 isoform X1
transducin-like enhancer protein 1 isoform X2
transducin-like enhancer protein 1 isoform X3
transducin-like enhancer protein 2-like, transcript variant X2
transducin-like enhancer protein 2-like, transcript variant X4
transducin-like enhancer protein 2-like, transcript variant X3
transducin-like enhancer protein 2-like, transcript variant X1
transducin-like enhancer protein 2 isoform X2
transducin-like enhancer protein 2 isoform X1
transducin-like enhancer protein 2 isoform X3
amino-terminal enhancer of split, transcript variant X2
amino-terminal enhancer of split, transcript variant X1
G protein subunit alpha 11; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
guanine nucleotide-binding protein subunit alpha-11
G protein subunit alpha 11, transcript variant X1
guanine nucleotide-binding protein subunit alpha-11 isoform X1
sphingosine-1-phosphate receptor 4, transcript variant X1
nicalin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
CUGBP Elav-like family member 5, transcript variant X1
CUGBP Elav-like family member 5, transcript variant X5
CUGBP Elav-like family member 5, transcript variant X2
CUGBP Elav-like family member 5, transcript variant X6
CUGBP Elav-like family member 5 isoform X1
CUGBP Elav-like family member 5 isoform X5
CUGBP Elav-like family member 5 isoform X2
CUGBP Elav-like family member 5, transcript variant X3
CUGBP Elav-like family member 5, transcript variant X4
CUGBP Elav-like family member 5 isoform X3
CUGBP Elav-like family member 5 isoform X4
CUGBP Elav-like family member 5 isoform X6
11-BETA-HSD3; 11-DH3; HSD3; SCDR10; SCDR10B; SDR26C2
hydroxysteroid 11-beta dehydrogenase 1 like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X13
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X15
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X14
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X7
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X1
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X10
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X5
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X2
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X4
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X6
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant 3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant 2
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X6
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X2
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X5
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X1
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X4
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X11
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X12
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X9
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X8
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant 1
isoform 1 precursor is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform 1 precursor
/evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q6PUF4.1)
isoform 1 precursor is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X3
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant X16
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform X7
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant 4
hydroxysteroid 11-beta dehydrogenase 1 like, transcript variant 5
isoform 2 precursor is encoded by transcript variant 5; Derived by automated computational analysis using gene prediction method: BestRefSeq.
hydroxysteroid 11-beta-dehydrogenase 1-like protein isoform 2 precursor
isoform 2 precursor is encoded by transcript variant 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
scaffold attachment factor B, transcript variant X1
scaffold attachment factor B, transcript variant X2
scaffold attachment factor B1 isoform X1
scaffold attachment factor B1 isoform X2
scaffold attachment factor B2, transcript variant X3
scaffold attachment factor B2, transcript variant X1
scaffold attachment factor B2, transcript variant X2
scaffold attachment factor B2, transcript variant X5
scaffold attachment factor B2, transcript variant X4
scaffold attachment factor B2, transcript variant X6
scaffold attachment factor B2, transcript variant X8
scaffold attachment factor B1 isoform X3
scaffold attachment factor B2 isoform X4
scaffold attachment factor B1 isoform X5
scaffold attachment factor B2 isoform X7
scaffold attachment factor B2, transcript variant X7
scaffold attachment factor B2 isoform X6
microRNA 1774; Derived by automated computational analysis using gene prediction method: BestRefSeq.
MPN domain containing, transcript variant X5
MPN domain containing, transcript variant X2
MPN domain containing, transcript variant X4
MPN domain containing, transcript variant X1
MPN domain containing, transcript variant X3
MPN domain-containing protein isoform X2
MPN domain-containing protein isoform X1
MPN domain-containing protein isoform X3
MPN domain-containing protein isoform X5
MPN domain-containing protein isoform X4
signal transducing adaptor family member 2, transcript variant X1
signal transducing adaptor family member 2, transcript variant X3
signal transducing adaptor family member 2, transcript variant X4
signal transducing adaptor family member 2, transcript variant X2
signal-transducing adaptor protein 2 isoform X1
signal-transducing adaptor protein 2 isoform X2
signal-transducing adaptor protein 2 isoform X3
fibronectin type III and SPRY domain-containing protein 1-like, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: fibronectin type III and SPRY domain-containing protein 1 isoform X1
transmembrane and immunoglobulin domain containing 2, transcript variant X1
transmembrane and immunoglobulin domain containing 2, transcript variant X4
transmembrane and immunoglobulin domain containing 2, transcript variant X2
transmembrane and immunoglobulin domain containing 2, transcript variant X5
transmembrane and immunoglobulin domain-containing protein 2 isoform X1
transmembrane and immunoglobulin domain-containing protein 2 isoform X4
transmembrane and immunoglobulin domain-containing protein 2 isoform X2
transmembrane and immunoglobulin domain-containing protein 2 isoform X5
transmembrane and immunoglobulin domain containing 2, transcript variant X3
transmembrane and immunoglobulin domain-containing protein 2 isoform X3
Src homology 2 domain containing transforming protein D, transcript variant X1
SH2 domain-containing adapter protein D isoform X1
coiled-coil domain containing 94; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 6593; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence (same species):RefSeq:NR_105462.1
The RefSeq transcript has 1 non-frameshifting indel compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
zinc finger and BTB domain containing 7A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
zinc finger and BTB domain containing 7A
zinc finger and BTB domain containing 7A, transcript variant X1
zinc finger and BTB domain containing 7A, transcript variant X2
zinc finger and BTB domain-containing protein 7A isoform X2
zinc finger and BTB domain-containing protein 7A isoform X1
zinc finger and BTB domain-containing protein 7A
propagated from UniProtKB/Swiss-Prot (O93567.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
protein inhibitor of activated STAT 4, transcript variant X1
protein inhibitor of activated STAT 4, transcript variant X2
protein inhibitor of activated STAT 4, transcript variant X3
eukaryotic translation elongation factor 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
eukaryotic translation elongation factor 2
Phosphothreonine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q90705.3); phosphorylation site
Small nucleolar RNA SNORD37; Derived by automated computational analysis using gene prediction method: BestRefSeq.
death-associated protein kinase 3, transcript variant X1
death-associated protein kinase 3, transcript variant X2
death-associated protein kinase 3 isoform X1
death-associated protein kinase 3 isoform X2
nicotinamide riboside kinase 2, transcript variant X2
nicotinamide riboside kinase 2, transcript variant X1
nicotinamide riboside kinase 2 isoform X2
nicotinamide riboside kinase 2 isoform X1
uncharacterized LOC107055337, transcript variant X6
uncharacterized LOC107055337, transcript variant X4
uncharacterized LOC107055337, transcript variant X7
uncharacterized LOC107055337, transcript variant X5
uncharacterized LOC107055337, transcript variant X1
uncharacterized LOC107055337, transcript variant X8
uncharacterized LOC107055337, transcript variant X2
uncharacterized LOC107055337, transcript variant X3
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6
neurturin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dihydrouridine synthase 3 like, transcript variant X2
dihydrouridine synthase 3 like, transcript variant X1
tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
La ribonucleoprotein domain family member 6; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
La ribonucleoprotein domain family member 6, transcript variant X1
La ribonucleoprotein domain family member 6
La ribonucleoprotein domain family, member 6-like
la ribonucleoprotein domain family, member 6-like isoform X1
regulatory factor X2, transcript variant X8
regulatory factor X2, transcript variant X13
regulatory factor X2, transcript variant X10
regulatory factor X2, transcript variant X6
regulatory factor X2, transcript variant X2
regulatory factor X2, transcript variant X14
regulatory factor X2, transcript variant X12
regulatory factor X2, transcript variant X9
regulatory factor X2, transcript variant X11
regulatory factor X2, transcript variant X7
regulatory factor X2, transcript variant X4
regulatory factor X2, transcript variant X3
regulatory factor X2, transcript variant X1
regulatory factor X2, transcript variant X5
acyl-CoA synthetase bubblegum family member 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
acyl-CoA synthetase bubblegum family member 2
acyl-CoA synthetase bubblegum family member 2, transcript variant X3
acyl-CoA synthetase bubblegum family member 2, transcript variant X1
acyl-CoA synthetase bubblegum family member 2, transcript variant X2
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X1
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X2
long-chain-fatty-acid--CoA ligase ACSBG2
propagated from UniProtKB/Swiss-Prot (Q5ZKR7.2); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X3
acyl-CoA synthetase bubblegum family member 2, transcript variant X6
acyl-CoA synthetase bubblegum family member 2, transcript variant X5
acyl-CoA synthetase bubblegum family member 2, transcript variant X4
long-chain-fatty-acid--CoA ligase ACSBG2 isoform X4
MLLT1, super elongation complex subunit, transcript variant X2
MLLT1, super elongation complex subunit, transcript variant X1
MLLT1, super elongation complex subunit, transcript variant X3
MLLT1, super elongation complex subunit, transcript variant X4
alkaline ceramidase 1, transcript variant X1
alkaline ceramidase 1, transcript variant X2
alkaline ceramidase 1, transcript variant X3
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B, transcript variant X1
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X1
acidic leucine-rich nuclear phosphoprotein 32 family member B
propagated from UniProtKB/Swiss-Prot (Q5ZMN0.1); Region: LRR 1
propagated from UniProtKB/Swiss-Prot (Q5ZMN0.1); Region: LRR 2
propagated from UniProtKB/Swiss-Prot (Q5ZMN0.1); Region: LRR 3
propagated from UniProtKB/Swiss-Prot (Q5ZMN0.1); Region: LRR 4
propagated from UniProtKB/Swiss-Prot (Q5ZMN0.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (Q5ZMN0.1); Region: Nuclear localization signal. /evidence=ECO:0000250|UniProtKB:Q92688
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B, transcript variant X3
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B, transcript variant X2
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X2
acidic leucine-rich nuclear phosphoprotein 32 family member B isoform X3
zinc finger protein 414, transcript variant X1
zinc finger protein 414, transcript variant X4
zinc finger protein 414, transcript variant X3
zinc finger protein 414, transcript variant X2
myosin IF; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ADAM metallopeptidase with thrombospondin type 1 motif, 10; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ADAM metallopeptidase with thrombospondin type 1 motif, 10
A disintegrin and metalloproteinase with thrombospondin motifs 10 precursor
microRNA 6615; Derived by automated computational analysis using gene prediction method: BestRefSeq.
zeta chain of T cell receptor associated protein kinase; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
zeta chain of T cell receptor associated protein kinase, transcript variant X1
zeta chain of T cell receptor associated protein kinase
zeta chain of T cell receptor associated protein kinase, transcript variant X2
tyrosine-protein kinase ZAP-70 isoform X1
nuclear factor interleukin-3-regulated protein-like, transcript variant X2
nuclear factor interleukin-3-regulated protein-like, transcript variant X1
mucin 16, cell surface associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments
lisH domain-containing protein C1711.05-like
leucine rich repeat and Ig domain containing 3, transcript variant X3
leucine rich repeat and Ig domain containing 3, transcript variant X2
leucine rich repeat and Ig domain containing 3, transcript variant X1
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
chromosome 19 open reading frame 35, transcript variant X1
chromosome 19 open reading frame 35, transcript variant X2
chromosome 19 open reading frame 35, transcript variant X3
ornithine decarboxylase antizyme 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
protein translation is dependent on +1 polyamine-induced ribosomal frameshift; Derived by automated computational analysis using gene prediction method: BestRefSeq.
cilia- and flagella-associated protein 251-like, transcript variant X4
cilia- and flagella-associated protein 251-like, transcript variant X12
cilia- and flagella-associated protein 251-like, transcript variant X2
cilia- and flagella-associated protein 251-like, transcript variant X9
cilia- and flagella-associated protein 251-like, transcript variant X7
cilia- and flagella-associated protein 251-like, transcript variant X6
cilia- and flagella-associated protein 251-like, transcript variant X10
cilia- and flagella-associated protein 251-like, transcript variant X3
cilia- and flagella-associated protein 251-like, transcript variant X11
cilia- and flagella-associated protein 251-like, transcript variant X5
cilia- and flagella-associated protein 251-like, transcript variant X1
cilia- and flagella-associated protein 251-like, transcript variant X8
cilia- and flagella-associated protein 251 isoform X1
cilia- and flagella-associated protein 251 isoform X2
anti-Mullerian hormone; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
anti-Mullerian hormone, transcript variant X2
anti-Mullerian hormone, transcript variant X1
splicing factor 3a subunit 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
splicing factor 3a subunit 2, transcript variant X2
splicing factor 3a subunit 2, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001004397.1
The RefSeq transcript has 2 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
pleckstrin homology domain containing J1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
pleckstrin homology domain containing J1
pleckstrin homology domain-containing family J member 1
DOT1 like histone lysine methyltransferase, transcript variant X8
DOT1 like histone lysine methyltransferase, transcript variant X7
DOT1 like histone lysine methyltransferase, transcript variant X4
DOT1 like histone lysine methyltransferase, transcript variant X6
DOT1 like histone lysine methyltransferase, transcript variant X2
DOT1 like histone lysine methyltransferase, transcript variant X5
DOT1 like histone lysine methyltransferase, transcript variant X1
DOT1 like histone lysine methyltransferase, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X8
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X7
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X6
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X5
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X4
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
adaptor related protein complex 3 delta 1 subunit, transcript variant X1
adaptor related protein complex 3 delta 1 subunit, transcript variant X2
MOB kinase activator 3A, transcript variant X1
MOB kinase activator 3A, transcript variant X2
MAPK interacting serine/threonine kinase 2
MAP kinase-interacting serine/threonine-protein kinase 2
uncharacterized LOC121107743, transcript variant X3
uncharacterized LOC121107743, transcript variant X1
uncharacterized LOC121107743, transcript variant X2
BTB domain containing 2, transcript variant X1
BTB domain containing 2, transcript variant X2
casein kinase 1 gamma 2, transcript variant X7
casein kinase 1 gamma 2, transcript variant X2
casein kinase 1 gamma 2, transcript variant X6
casein kinase 1 gamma 2, transcript variant X8
casein kinase 1 gamma 2, transcript variant X3
casein kinase 1 gamma 2, transcript variant X1
casein kinase 1 gamma 2, transcript variant X5
casein kinase 1 gamma 2, transcript variant X4
secretory carrier membrane protein 4, transcript variant X1
secretory carrier membrane protein 4, transcript variant X2
secretory carrier-associated membrane protein 4
RAR related orphan receptor B like, transcript variant X2
RAR related orphan receptor B like, transcript variant X1
nuclear receptor ROR-beta-like isoform X1
nuclear receptor ROR-beta-like isoform X2
uncharacterized LOC121107744, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
AN1-type zinc finger protein 5-like, transcript variant X2
AN1-type zinc finger protein 5-like, transcript variant X1
alpha/beta hydrolase domain-containing protein 17A
microRNA 211; Derived by automated computational analysis using gene prediction method: BestRefSeq.
RNA exonuclease 1 homolog, transcript variant X2
RNA exonuclease 1 homolog, transcript variant X1
RNA exonuclease 1 homolog, transcript variant X3
RNA exonuclease 1 homolog, transcript variant X4
microRNA 1647; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ATPase phospholipid transporting 8B3, transcript variant X2
ATPase phospholipid transporting 8B3, transcript variant X4
ATPase phospholipid transporting 8B3, transcript variant X1
ATPase phospholipid transporting 8B3, transcript variant X3
ATPase phospholipid transporting 8B3, transcript variant X8
ATPase phospholipid transporting 8B3, transcript variant X5
phospholipid-transporting ATPase IK isoform X2
phospholipid-transporting ATPase IK isoform X5
phospholipid-transporting ATPase IK isoform X1
phospholipid-transporting ATPase IK isoform X3
ATPase phospholipid transporting 8B3, transcript variant X6
ATPase phospholipid transporting 8B3, transcript variant X7
phospholipid-transporting ATPase IK isoform X4
transcription factor 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
transcription factor 3, transcript variant X1
transcription factor 3, transcript variant X4
transcription factor 3, transcript variant X6
transcription factor 3, transcript variant X5
transcription factor 3, transcript variant X9
transcription factor 3, transcript variant X10
transcription factor 3, transcript variant X14
transcription factor 3, transcript variant X18
transcription factor 3, transcript variant X28
transcription factor 3, transcript variant X30
transcription factor 3, transcript variant X2
transcription factor 3, transcript variant X7
transcription factor 3, transcript variant X15
transcription factor 3, transcript variant X20
transcription factor 3, transcript variant X22
transcription factor 3, transcript variant X24
transcription factor 3, transcript variant X29
transcription factor 3, transcript variant X33
transcription factor 3, transcript variant X3
transcription factor 3, transcript variant X16
transcription factor 3, transcript variant X25
transcription factor 3, transcript variant X31
transcription factor 3, transcript variant X35
transcription factor 3, transcript variant X8
transcription factor 3, transcript variant X11
transcription factor 3, transcript variant X17
transcription factor 3, transcript variant X23
transcription factor 3, transcript variant X26
transcription factor 3, transcript variant X27
transcription factor 3, transcript variant X34
transcription factor 3, transcript variant X37
transcription factor 3, transcript variant X19
transcription factor 3, transcript variant X21
transcription factor 3, transcript variant X38
transcription factor 3, transcript variant X48
transcription factor 3, transcript variant X49
transcription factor E2-alpha isoform X1
transcription factor E2-alpha isoform X4
transcription factor E2-alpha isoform X6
transcription factor E2-alpha isoform X5
transcription factor E2-alpha isoform X9
transcription factor E2-alpha isoform X10
transcription factor E2-alpha isoform X14
transcription factor E2-alpha isoform X18
transcription factor E2-alpha isoform X28
transcription factor E2-alpha isoform X30
transcription factor E2-alpha isoform X2
transcription factor E2-alpha isoform X7
transcription factor E2-alpha isoform X15
transcription factor E2-alpha isoform X20
transcription factor E2-alpha isoform X22
transcription factor E2-alpha isoform X24
transcription factor E2-alpha isoform X29
transcription factor E2-alpha isoform X33
transcription factor E2-alpha isoform X3
transcription factor E2-alpha isoform X16
transcription factor E2-alpha isoform X25
transcription factor E2-alpha isoform X31
transcription factor E2-alpha isoform X35
transcription factor E2-alpha isoform X8
transcription factor E2-alpha isoform X11
transcription factor E2-alpha isoform X17
transcription factor E2-alpha isoform X23
transcription factor E2-alpha isoform X26
transcription factor E2-alpha isoform X27
transcription factor E2-alpha isoform X34
transcription factor E2-alpha isoform X37
transcription factor E2-alpha isoform X19
transcription factor E2-alpha isoform X21
transcription factor E2-alpha isoform X38
transcription factor 3, transcript variant X32
transcription factor 3, transcript variant X41
transcription factor 3, transcript variant X44
transcription factor 3, transcript variant X39
transcription factor 3, transcript variant X42
transcription factor 3, transcript variant X43
transcription factor 3, transcript variant X45
transcription factor 3, transcript variant X36
transcription factor 3, transcript variant X40
transcription factor 3, transcript variant X46
transcription factor 3, transcript variant X47
transcription factor E2-alpha isoform X32
transcription factor E2-alpha isoform X41
transcription factor E2-alpha isoform X44
transcription factor E2-alpha isoform X39
transcription factor E2-alpha isoform X42
transcription factor E2-alpha isoform X43
transcription factor E2-alpha isoform X45
transcription factor E2-alpha isoform X36
transcription factor E2-alpha isoform X40
transcription factor E2-alpha isoform X46
transcription factor E2-alpha isoform X47
transcription factor 3, transcript variant X12
transcription factor 3, transcript variant X13
transcription factor E2-alpha isoform X12
transcription factor E2-alpha isoform X13
transcription factor E2-alpha isoform X48
ubiquinol-cytochrome c reductase, complex III subunit XI; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ubiquinol-cytochrome c reductase, complex III subunit XI
methyl-CpG binding domain protein 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
methyl-CpG binding domain protein 3, transcript variant X1
methyl-CpG-binding domain protein 3 isoform X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001079751.2
The RefSeq transcript has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
methyl-CpG binding domain protein 3, transcript variant X4
methyl-CpG binding domain protein 3, transcript variant X3
methyl-CpG binding domain protein 3, transcript variant X2
methyl-CpG-binding domain protein 3 isoform X3
methyl-CpG-binding domain protein 3 isoform X2
methyl-CpG-binding domain protein 3 isoform X4
uncharacterized LOC121107747, transcript variant X1
MIER family member 2, transcript variant X9
MIER family member 2, transcript variant X8
MIER family member 2, transcript variant X7
MIER family member 2, transcript variant X5
MIER family member 2, transcript variant X4
MIER family member 2, transcript variant X3
MIER family member 2, transcript variant X1
MIER family member 2, transcript variant X6
MIER family member 2, transcript variant X2
mesoderm induction early response protein 2 isoform X4
mesoderm induction early response protein 2 isoform X3
mesoderm induction early response protein 2 isoform X1
mesoderm induction early response protein 2 isoform X7
mesoderm induction early response protein 2 isoform X6
mesoderm induction early response protein 2 isoform X2
mesoderm induction early response protein 2 isoform X5
mesoderm induction early response protein 2 isoform X8
SH3 domain containing GRB2 like 1, endophilin A2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X2
SH3 domain containing GRB2 like 1, endophilin A2
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X4
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X3
SH3 domain containing GRB2 like 1, endophilin A2, transcript variant X1
propagated from UniProtKB/Swiss-Prot (Q8AXV0.1); Region: Membrane-binding amphipathic helix. /evidence=ECO:0000250|UniProtKB:O35179
propagated from UniProtKB/Swiss-Prot (Q8AXV0.1); Region: Required for dimerization upon membrane association. /evidence=ECO:0000250|UniProtKB:O35179
propagated from UniProtKB/Swiss-Prot (Q8AXV0.1); Region: Interaction with ARC. /evidence=ECO:0000250|UniProtKB:O35964
propagated from UniProtKB/Swiss-Prot (Q8AXV0.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
chromatin assembly factor 1 subunit A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
chromatin assembly factor 1 subunit A, transcript variant X2
chromatin assembly factor 1 subunit A, transcript variant X1
propagated from UniProtKB/Swiss-Prot (Q5R1T0.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (Q5R1T0.1); Region: PxVxL motif. /evidence=ECO:0000250
chromatin assembly factor 1 subunit A isoform X1
UBX domain protein 6, transcript variant X4
UBX domain protein 6, transcript variant X3
UBX domain protein 6, transcript variant X2
UBX domain protein 6, transcript variant X1
UBX domain-containing protein 6 isoform X3
UBX domain-containing protein 6 isoform X2
UBX domain-containing protein 6 isoform X1
UBX domain-containing protein 6 isoform X4
hepatoma-derived growth factor-related protein 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
hepatoma-derived growth factor-related protein 2, transcript variant X1
hepatoma-derived growth factor-related protein 2, transcript variant X2
hepatoma-derived growth factor-related protein 2, transcript variant X3
hepatoma-derived growth factor-related protein 2
hepatoma-derived growth factor-related protein 2 isoform X1
hepatoma-derived growth factor-related protein 2 isoform X2
hepatoma-derived growth factor-related protein 2 isoform X3
perilipin 4; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 38 long SRA reads, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
semaphorin 6B; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ankyrin repeat domain 24, transcript variant X7
ankyrin repeat domain 24, transcript variant X3
ankyrin repeat domain 24, transcript variant X2
ankyrin repeat domain 24, transcript variant X6
ankyrin repeat domain 24, transcript variant X5
ankyrin repeat domain 24, transcript variant X1
ankyrin repeat domain 24, transcript variant X4
ankyrin repeat domain-containing protein 24 isoform X6
ankyrin repeat domain-containing protein 24 isoform X7
ankyrin repeat domain-containing protein 24 isoform X3
ankyrin repeat domain-containing protein 24 isoform X2
ankyrin repeat domain-containing protein 24 isoform X5
ankyrin repeat domain-containing protein 24 isoform X1
ankyrin repeat domain-containing protein 24 isoform X4
sirtuin 6; Derived by automated computational analysis using gene prediction method: BestRefSeq.
NAD-dependent protein deacetylase sirtuin-6
cAMP responsive element binding protein 3 like 3, transcript variant X2
cAMP responsive element binding protein 3 like 3, transcript variant X1
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X2
cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1
mitogen-activated protein kinase kinase 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
mitogen-activated protein kinase kinase 2, transcript variant X1
mitogen-activated protein kinase kinase 2
dual specificity mitogen-activated protein kinase kinase 2 isoform X1
dual specificity mitogen-activated protein kinase kinase 2
propagated from UniProtKB/Swiss-Prot (Q90891.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
Phosphoserine, by RAF. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q90891.1); phosphorylation site
C2 calcium dependent domain containing 4C, transcript variant X2
C2 calcium dependent domain containing 4C, transcript variant X1
C2 calcium dependent domain containing 4C, transcript variant X3
C2 calcium dependent domain containing 4C, transcript variant X4
C2 calcium-dependent domain-containing protein 4C
SHC (Src homology 2 domain containing) transforming protein 2, transcript variant X4
SHC (Src homology 2 domain containing) transforming protein 2, transcript variant X3
SHC (Src homology 2 domain containing) transforming protein 2, transcript variant X2
SHC (Src homology 2 domain containing) transforming protein 2, transcript variant X1
hyperpolarization activated cyclic nucleotide-gated potassium channel 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
hyperpolarization activated cyclic nucleotide-gated potassium channel 2
hyperpolarization activated cyclic nucleotide-gated potassium channel 2, transcript variant X1
hyperpolarization activated cyclic nucleotide-gated potassium channel 2, transcript variant X2
hippocampus abundant transcript 1 protein isoform X1
hippocampus abundant transcript 1 protein
hippocampus abundant transcript 1 protein isoform X2
mucosal vascular addressin cell adhesion molecule 1
mucosal addressin cell adhesion molecule 1
tubulin polyglutamylase complex subunit 1
cell division cycle 34, ubiqiutin conjugating enzyme
basigin (Ok blood group); Derived by automated computational analysis using gene prediction method: BestRefSeq.
basigin (Ok blood group), transcript variant 1
basigin (Ok blood group), transcript variant 2
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X1
hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2, transcript variant X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 isoform X2
RNA polymerase mitochondrial, transcript variant X1
DNA-directed RNA polymerase, mitochondrial isoform X1
RNA polymerase mitochondrial, transcript variant X3
RNA polymerase mitochondrial, transcript variant X2
DNA-directed RNA polymerase, mitochondrial isoform X2
RNA polymerase mitochondrial, transcript variant X4
DNA-directed RNA polymerase, mitochondrial isoform X3
fibroblast growth factor 22, transcript variant X2
fibroblast growth factor 22, transcript variant X5
fibroblast growth factor 22, transcript variant X6
fibroblast growth factor 22, transcript variant X1
fibroblast growth factor 22, transcript variant X3
fibroblast growth factor 22, transcript variant X4
ring finger protein 126; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ring finger protein 126, transcript variant X2
E3 ubiquitin-protein ligase RNF126 isoform X1
ring finger protein 126, transcript variant X1
protease, serine 57, transcript variant X2
protease, serine 57, transcript variant X1
paralemmin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
putative protein TPRXL-like, transcript variant X2
putative protein TPRXL-like, transcript variant X1
mitotic spindle positioning, transcript variant X1
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitotic interactor and substrate of PLK1 isoform X1
uncharacterized LOC101750583, transcript variant X3
uncharacterized LOC101750583, transcript variant X6
uncharacterized LOC101750583, transcript variant X8
uncharacterized LOC101750583, transcript variant X4
uncharacterized LOC101750583, transcript variant X2
uncharacterized LOC101750583, transcript variant X7
uncharacterized LOC101750583, transcript variant X5
uncharacterized LOC101750583, transcript variant X9
uncharacterized LOC101750583, transcript variant X1
polypyrimidine tract binding protein 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001030935.1
The RefSeq transcript has 13 substitutions, 7 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
polypyrimidine tract binding protein 1, transcript variant X1
polypyrimidine tract binding protein 1, transcript variant X2
polypyrimidine tract binding protein 1, transcript variant X3
polypyrimidine tract-binding protein 1 isoform X1
polypyrimidine tract-binding protein 1 isoform X2
polypyrimidine tract binding protein 1, transcript variant X4
polypyrimidine tract-binding protein 1 isoform X3
similar to AA sequence (same species):RefSeq:NP_001026106.1
The RefSeq protein has 1 substitution compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
phospholipid phosphatase-related protein type 3
mediator of RNA polymerase II transcription subunit 16
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
R3H domain containing 4, transcript variant X1
R3H domain-containing protein 4 isoform X1
AT-rich interactive domain-containing protein 3A
uncharacterized LOC101750993, transcript variant X1
WD repeat domain 18; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
WD repeat domain 18, transcript variant X1
WD repeat-containing protein 18 isoform X1
glutamate ionotropic receptor NMDA type subunit 3B
transmembrane protein 259, transcript variant X2
transmembrane protein 259, transcript variant X1
ATP-binding cassette, sub-family A (ABC1), member 7, transcript variant X1
phospholipid-transporting ATPase ABCA7 isoform X1
calponin 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Rho GTPase activating protein 45; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
Rho GTPase activating protein 45, transcript variant 1
Rho GTPase activating protein 45, transcript variant 2
Rho GTPase activating protein 45, transcript variant X5
Rho GTPase activating protein 45, transcript variant 3
rho GTPase-activating protein 45 isoform 1
rho GTPase-activating protein 45 isoform 2
rho GTPase-activating protein 45 isoform X5
rho GTPase-activating protein 45 isoform 3
Rho GTPase activating protein 45, transcript variant X1
Rho GTPase activating protein 45, transcript variant X2
Rho GTPase activating protein 45, transcript variant X3
Rho GTPase activating protein 45, transcript variant X4
rho GTPase-activating protein 45 isoform X1
rho GTPase-activating protein 45 isoform X2
rho GTPase-activating protein 45 isoform X3
rho GTPase-activating protein 45 isoform X4
DNA-directed RNA polymerases I, II, and III subunit RPABC1
glutathione peroxidase 4; Derived by automated computational analysis using gene prediction method: BestRefSeq.
glutathione peroxidase 4, transcript variant 2
glutathione peroxidase 4, transcript variant 1
glutathione peroxidase 4, transcript variant 3
UGA stop codon recoded as selenocysteine; isoform B precursor is encoded by transcript variant 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
phospholipid hydroperoxide glutathione peroxidase, mitochondrial isoform B precursor
UGA stop codon recoded as selenocysteine; isoform A precursor is encoded by transcript variant 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
phospholipid hydroperoxide glutathione peroxidase, mitochondrial isoform A precursor
UGA stop codon recoded as selenocysteine; isoform C is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
phospholipid hydroperoxide glutathione peroxidase isoform C
strawberry notch homolog 2, transcript variant X2
strawberry notch homolog 2, transcript variant X1
strawberry notch homolog 2, transcript variant X4
strawberry notch homolog 2, transcript variant X3
strawberry notch homolog 2, transcript variant X7
strawberry notch homolog 2, transcript variant X6
strawberry notch homolog 2, transcript variant X8
strawberry notch homolog 2, transcript variant X5
protein strawberry notch homolog 2 isoform X1
protein strawberry notch homolog 2 isoform X2
protein strawberry notch homolog 2 isoform X5
protein strawberry notch homolog 2 isoform X4
protein strawberry notch homolog 2 isoform X3
serine/threonine kinase 11; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
serine/threonine kinase 11, transcript variant X1
similar to RNA sequence, mRNA (same species):RefSeq:NM_001045833.1
Phosphothreonine, by autocatalysis. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q0GGW5.1); phosphorylation site
propagated from UniProtKB/Swiss-Prot (Q0GGW5.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
Phosphoserine, by PKA. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (Q0GGW5.1); phosphorylation site
serine/threonine-protein kinase STK11 isoform X1
CACN beta subunit associated regulatory protein, transcript variant X1
voltage-dependent calcium channel beta subunit-associated regulatory protein isoform X1
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit, transcript variant X1
ATP synthase subunit delta, mitochondrial isoform X1
uncharacterized LOC121107749, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC121107749, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC121107749 isoform X1
RNA binding motif (RNP1, RRM) protein 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
RNA binding motif (RNP1, RRM) protein 3, transcript variant X4
RNA binding motif (RNP1, RRM) protein 3, transcript variant X5
RNA binding motif (RNP1, RRM) protein 3, transcript variant X1
RNA binding motif (RNP1, RRM) protein 3, transcript variant X2
similar to RNA sequence, mRNA (same species):RefSeq:NM_001031347.1
The RefSeq transcript has 1 substitution, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
RNA binding motif (RNP1, RRM) protein 3, transcript variant X3
cold-inducible RNA-binding protein isoform X2
cold-inducible RNA-binding protein isoform X3
cold-inducible RNA-binding protein isoform X1
ephrin A2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_204983.1
similar to AA sequence (same species):RefSeq:NP_990314.1
/evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P52802.1)
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (P52802.1); glycosylation site
calcium/calmodulin-dependent protein kinase IV-like, transcript variant X1
calcium/calmodulin-dependent protein kinase IV-like, transcript variant X2
calcium/calmodulin-dependent protein kinase IV-like, transcript variant X3
calcium/calmodulin-dependent protein kinase type IV
MUM1 like 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001282239.1
The RefSeq transcript has 8 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001269168.1
PWWP domain-containing DNA repair factor 3A
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
NADH:ubiquinone oxidoreductase core subunit S7
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial
guanidinoacetate N-methyltransferase, transcript variant X1
guanidinoacetate N-methyltransferase, transcript variant X2
guanidinoacetate N-methyltransferase isoform X1
guanidinoacetate N-methyltransferase isoform X2
DAZ associated protein 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
DAZ associated protein 1, transcript variant X1
DAZ associated protein 1, transcript variant X2
DAZ associated protein 1, transcript variant X3
similar to RNA sequence, mRNA (same species):RefSeq:NM_001031428.1
The RefSeq transcript has 4 substitutions, 3 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
DAZ associated protein 1, transcript variant X6
DAZ associated protein 1, transcript variant X4
DAZ associated protein 1, transcript variant X5
DAZ associated protein 1, transcript variant X7
uncharacterized LOC121107752, transcript variant X1
ribosomal protein S15; Derived by automated computational analysis using gene prediction method: BestRefSeq.
N-acetylalanine. /evidence=ECO:0000250; propagated from UniProtKB/Swiss-Prot (P62846.2); acetylation site
APC2, WNT signaling pathway regulator; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 1777; Derived by automated computational analysis using gene prediction method: BestRefSeq.
LOW QUALITY PROTEIN: UPF0449 protein C19orf25 homolog
receptor accessory protein 6, transcript variant X1
receptor accessory protein 6, transcript variant X2
receptor expression-enhancing protein 6 isoform X1
receptor expression-enhancing protein 6 isoform X2
proprotein convertase subtilisin/kexin type 4, transcript variant X1
proprotein convertase subtilisin/kexin type 4 isoform X1
small glutamine rich tetratricopeptide repeat containing alpha; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X7
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X4
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X5
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X6
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X3
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X1
small glutamine rich tetratricopeptide repeat containing alpha, transcript variant X2
small glutamine rich tetratricopeptide repeat containing alpha
similar to RNA sequence, mRNA (same species):RefSeq:NM_001031379.2
small glutamine-rich tetratricopeptide repeat-containing protein alpha isoform X1
small glutamine-rich tetratricopeptide repeat-containing protein alpha isoform X2
small glutamine-rich tetratricopeptide repeat-containing protein alpha
solute carrier family 39 member 3, transcript variant X3
solute carrier family 39 member 3, transcript variant X1
solute carrier family 39 member 3, transcript variant X2
G protein subunit gamma 7, transcript variant X6
G protein subunit gamma 7, transcript variant X4
G protein subunit gamma 7, transcript variant X8
G protein subunit gamma 7, transcript variant X3
uncharacterized LOC107055350, transcript variant X2
uncharacterized LOC107055350, transcript variant X1
uncharacterized LOC107055350, transcript variant X3
G protein subunit gamma 7, transcript variant X1
G protein subunit gamma 7, transcript variant X5
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 isoform X1
G protein subunit gamma 7, transcript variant X7
G protein subunit gamma 7, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 isoform X2
guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 isoform X3
growth arrest and DNA damage inducible beta, transcript variant X1
growth arrest and DNA damage inducible beta, transcript variant X2
growth arrest and DNA damage-inducible protein GADD45 beta isoform X1
growth arrest and DNA damage-inducible protein GADD45 beta isoform X2
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X5
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X6
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X7
cocaine- and amphetamine-regulated transcript protein isoform X7
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X3
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X4
uncharacterized protein LOC100859819 isoform X3
uncharacterized protein LOC100859819 isoform X4
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X1
cocaine- and amphetamine-regulated transcript protein-like, transcript variant X2
uncharacterized protein LOC100859819 isoform X1
cocaine- and amphetamine-regulated transcript protein isoform X2
cocaine- and amphetamine-regulated transcript protein isoform X5
cocaine- and amphetamine-regulated transcript protein isoform X6
FCH domain only protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
FCH domain only protein 1-like, transcript variant X2
FCH domain only protein 1-like, transcript variant X3
FCH domain only protein 1-like, transcript variant X1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3
Janus kinase 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_204996.3
The RefSeq transcript has 28 substitutions, 6 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_990327.2
The RefSeq protein has 9 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
solute carrier family 5 member 5, transcript variant X1
solute carrier family 5 member 5, transcript variant X2
solute carrier family 5 member 5, transcript variant X3
solute carrier family 5 member 5, transcript variant X7
solute carrier family 5 member 5, transcript variant X4
solute carrier family 5 member 5, transcript variant X5
solute carrier family 5 member 5, transcript variant X6
solute carrier family 5 member 5, transcript variant X8
solute carrier family 5 member 5, transcript variant X11
solute carrier family 5 member 5, transcript variant X9
solute carrier family 5 member 5, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain containing 124, transcript variant X1
coiled-coil domain containing 124, transcript variant X3
coiled-coil domain containing 124, transcript variant X2
coiled-coil domain containing 124, transcript variant X4
coiled-coil domain-containing protein 124
potassium calcium-activated channel subfamily N member 1, transcript variant X7
potassium calcium-activated channel subfamily N member 1, transcript variant X1
potassium calcium-activated channel subfamily N member 1, transcript variant X3
potassium calcium-activated channel subfamily N member 1, transcript variant X2
potassium calcium-activated channel subfamily N member 1, transcript variant X4
potassium calcium-activated channel subfamily N member 1, transcript variant X6
potassium calcium-activated channel subfamily N member 1, transcript variant X5
potassium calcium-activated channel subfamily N member 1, transcript variant X9
small conductance calcium-activated potassium channel protein 1 isoform X1
small conductance calcium-activated potassium channel protein 1 isoform X3
small conductance calcium-activated potassium channel protein 1 isoform X2
small conductance calcium-activated potassium channel protein 1 isoform X4
small conductance calcium-activated potassium channel protein 1 isoform X6
small conductance calcium-activated potassium channel protein 1 isoform X5
potassium calcium-activated channel subfamily N member 1, transcript variant X8
small conductance calcium-activated potassium channel protein 1 isoform X7
occludin/ELL domain-containing protein 1
occludin; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
similar to RNA sequence, mRNA (same species):RefSeq:NM_205128.1
The RefSeq transcript has 15 substitutions, 2 non-frameshifting indels compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
propagated from UniProtKB/Swiss-Prot (Q91049.1); transmembrane region
propagated from UniProtKB/Swiss-Prot (Q91049.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (Q91049.1); Region: Interaction with TJP1. /evidence=ECO:0000269|PubMed:19017651
Phosphotyrosine. /evidence=ECO:0000269|PubMed:19017651; propagated from UniProtKB/Swiss-Prot (Q91049.1); phosphorylation site
nuclear receptor subfamily 2 group F member 6, transcript variant X1
nuclear receptor subfamily 2 group F member 6, transcript variant X2
nuclear receptor subfamily 2 group F member 6 isoform X1
nuclear receptor subfamily 2 group F member 6 isoform X2
USH1 protein network component harmonin binding protein 1, transcript variant X4
USH1 protein network component harmonin binding protein 1, transcript variant X3
USH1 protein network component harmonin binding protein 1, transcript variant X2
USH1 protein network component harmonin binding protein 1, transcript variant X1
Usher syndrome type-1C protein-binding protein 1 isoform X3
Usher syndrome type-1C protein-binding protein 1 isoform X1
Usher syndrome type-1C protein-binding protein 1 isoform X4
Usher syndrome type-1C protein-binding protein 1 isoform X2
BRISC and BRCA1 A complex member 1, transcript variant X4
BRISC and BRCA1 A complex member 1, transcript variant X3
BRISC and BRCA1 A complex member 1, transcript variant X6
BRISC and BRCA1 A complex member 1, transcript variant X5
BRISC and BRCA1 A complex member 1, transcript variant X2
BRISC and BRCA1 A complex member 1, transcript variant X1
BRISC and BRCA1-A complex member 1 isoform X1
BRISC and BRCA1-A complex member 1 isoform X2
BRISC and BRCA1-A complex member 1 isoform X3
BRISC and BRCA1-A complex member 1 isoform X4
ankyrin repeat and LEM domain containing 1, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ankyrin repeat and LEM domain-containing protein 1 isoform X1
abhydrolase domain containing 8, transcript variant X2
abhydrolase domain containing 8, transcript variant X1
abhydrolase domain containing 8, transcript variant X3
mitochondrial ribosomal protein L34; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001302186.1
The RefSeq transcript has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to AA sequence (same species):RefSeq:NP_001289115.1
39S ribosomal protein L34, mitochondrial
DET1 and DDB1 associated 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
DET1 and DDB1 associated 1, transcript variant X1
DET1 and DDB1 associated 1, transcript variant 2
DET1 and DDB1 associated 1, transcript variant 3
DET1- and DDB1-associated protein 1 isoform 2
propagated from UniProtKB/Swiss-Prot (Q5ZK14.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
DET1- and DDB1-associated protein 1 isoform 3
DET1 and DDB1 associated 1, transcript variant 1
DET1- and DDB1-associated protein 1 isoform 1
DET1- and DDB1-associated protein 1 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: anoctamin-8 isoform X1
GTP binding protein 3 (mitochondrial), transcript variant X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X1
GTP binding protein 3 (mitochondrial), transcript variant X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
YjeF N-terminal domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
YjeF N-terminal domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
YjeF N-terminal domain containing 3, transcript variant X3
YjeF N-terminal domain containing 3, transcript variant X2
yjeF N-terminal domain-containing protein 3 isoform X2
yjeF N-terminal domain-containing protein 3 isoform X3
yjeF N-terminal domain-containing protein 3 isoform X1
yjeF N-terminal domain-containing protein 3 isoform X5
YjeF N-terminal domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
yjeF N-terminal domain-containing protein 3 isoform X4
NADH:ubiquinone oxidoreductase subunit A13
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13
GATA zinc finger domain containing 2A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
GATA zinc finger domain containing 2A, transcript variant X15
GATA zinc finger domain containing 2A, transcript variant X7
GATA zinc finger domain containing 2A, transcript variant X19
GATA zinc finger domain containing 2A, transcript variant X12
GATA zinc finger domain containing 2A, transcript variant X11
GATA zinc finger domain containing 2A, transcript variant X1
GATA zinc finger domain containing 2A, transcript variant X14
GATA zinc finger domain containing 2A, transcript variant X2
GATA zinc finger domain containing 2A, transcript variant X8
GATA zinc finger domain containing 2A, transcript variant X13
GATA zinc finger domain containing 2A, transcript variant X4
GATA zinc finger domain containing 2A, transcript variant X16
GATA zinc finger domain containing 2A, transcript variant X6
GATA zinc finger domain containing 2A, transcript variant X18
GATA zinc finger domain containing 2A, transcript variant X5
GATA zinc finger domain containing 2A, transcript variant X9
GATA zinc finger domain containing 2A, transcript variant X10
GATA zinc finger domain containing 2A, transcript variant X17
GATA zinc finger domain containing 2A, transcript variant X3
similar to RNA sequence, mRNA (same species):RefSeq:NM_001012552.2
transcriptional repressor p66-alpha isoform X4
transcriptional repressor p66-alpha isoform X3
transcriptional repressor p66-alpha isoform X2
transcriptional repressor p66-alpha isoform X1
uncharacterized LOC124417440, transcript variant X4
uncharacterized LOC124417440, transcript variant X3
uncharacterized LOC124417440, transcript variant X1
uncharacterized LOC124417440, transcript variant X2
SURP and G-patch domain containing 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
SURP and G-patch domain containing 1, transcript variant X1
SURP and G-patch domain containing 1, transcript variant X2
SURP and G-patch domain-containing protein 1 isoform X1
SURP and G-patch domain-containing protein 1 isoform X2
SURP and G-patch domain-containing protein 1
transmembrane 6 superfamily member 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
transmembrane 6 superfamily member 2, transcript variant X1
transmembrane 6 superfamily member 2 isoform X1
hyaluronan and proteoglycan link protein 4
neurocan; Derived by automated computational analysis using gene prediction method: BestRefSeq.
regulatory factor X associated ankyrin containing protein; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
regulatory factor X associated ankyrin containing protein
regulatory factor X associated ankyrin containing protein, transcript variant X2
regulatory factor X associated ankyrin containing protein, transcript variant X1
BLOC-1 related complex subunit 8; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
BLOC-1 related complex subunit 8, transcript variant 1
BLOC-1 related complex subunit 8, transcript variant 2
BLOC-1 related complex subunit 8, transcript variant X1
BLOC-1-related complex subunit 8 isoform X1
BLOC-1-related complex subunit 8 isoform 1
BLOC-1-related complex subunit 8 isoform 2
myocyte enhancer factor 2B, transcript variant X1
myocyte enhancer factor 2B, transcript variant X3
myocyte enhancer factor 2B, transcript variant X2
myocyte-specific enhancer factor 2B isoform X1
myocyte-specific enhancer factor 2B isoform X2
uncharacterized LOC107055364, transcript variant X4
uncharacterized protein LOC107055364 isoform X3
uncharacterized LOC107055364, transcript variant X7
uncharacterized LOC107055364, transcript variant X3
translation initiation factor IF-2 isoform X2
uncharacterized LOC107055364, transcript variant X5
microRNA 1621; Derived by automated computational analysis using gene prediction method: BestRefSeq.
microRNA 1565; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC107055364, transcript variant X6
microRNA 9-1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC107055364, transcript variant X1
uncharacterized LOC107055364, transcript variant X2
uncharacterized protein LOC107055364 isoform X1
transmembrane protein 161A, transcript variant X1
transmembrane protein 161A, transcript variant X2
transmembrane protein 161A, transcript variant X3
solute carrier family 25 member 42, transcript variant X2
solute carrier family 25 member 42, transcript variant X1
solute carrier family 25 member 42, transcript variant X4
solute carrier family 25 member 42, transcript variant X3
mitochondrial coenzyme A transporter SLC25A42 isoform X2
mitochondrial coenzyme A transporter SLC25A42 isoform X1
mitochondrial coenzyme A transporter SLC25A42 isoform X3
uncharacterized LOC124417444, transcript variant X2
uncharacterized protein LOC124417444 isoform X2
uncharacterized LOC124417444, transcript variant X1
uncharacterized protein LOC124417444 isoform X1
armadillo repeat containing 6, transcript variant X2
armadillo repeat containing 6, transcript variant X1
SURP and G-patch domain containing 2; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
SURP and G-patch domain containing 2, transcript variant X4
SURP and G-patch domain containing 2, transcript variant 1
SURP and G-patch domain containing 2, transcript variant 2
SURP and G-patch domain containing 2, transcript variant X1
SURP and G-patch domain containing 2, transcript variant X3
SURP and G-patch domain containing 2, transcript variant X2
SURP and G-patch domain containing 2, transcript variant X5
SURP and G-patch domain-containing protein 2 isoform 2
SURP and G-patch domain-containing protein 2 isoform X2
SURP and G-patch domain-containing protein 2 isoform 1
SURP and G-patch domain-containing protein 2 isoform X3
SURP and G-patch domain-containing protein 2 isoform X1
SURP and G-patch domain-containing protein 2 isoform X4
homer scaffolding protein 3, transcript variant X1
homer scaffolding protein 3, transcript variant X4
homer scaffolding protein 3, transcript variant X6
homer scaffolding protein 3, transcript variant X8
homer scaffolding protein 3, transcript variant X7
homer scaffolding protein 3, transcript variant X5
homer scaffolding protein 3, transcript variant X3
homer scaffolding protein 3, transcript variant X2
homer scaffolding protein 3, transcript variant X9
homer scaffolding protein 3, transcript variant X10
DEAD-box helicase 49; Derived by automated computational analysis using gene prediction method: BestRefSeq.
probable ATP-dependent RNA helicase DDX49
coatomer protein complex subunit epsilon; Derived by automated computational analysis using gene prediction method: BestRefSeq.
coatomer protein complex subunit epsilon
ceramide synthase 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
ceramide synthase 1, transcript variant X1
ceramide synthase 1, transcript variant X2
growth differentiation factor 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
embryonic growth/differentiation factor 1
UPF1, RNA helicase and ATPase, transcript variant X2
UPF1, RNA helicase and ATPase, transcript variant X1
regulator of nonsense transcripts 1 isoform X2
regulator of nonsense transcripts 1 isoform X1
CREB regulated transcription coactivator 1, transcript variant X4
CREB regulated transcription coactivator 1, transcript variant X2
CREB regulated transcription coactivator 1, transcript variant X3
CREB regulated transcription coactivator 1, transcript variant X1
CREB regulated transcription coactivator 1, transcript variant X5
CREB-regulated transcription coactivator 1 isoform X4
CREB-regulated transcription coactivator 1 isoform X2
CREB-regulated transcription coactivator 1 isoform X3
CREB-regulated transcription coactivator 1 isoform X1
CREB-regulated transcription coactivator 1 isoform X5
kelch like family member 26, transcript variant X5
uncharacterized LOC101748347, transcript variant X1
uncharacterized LOC101748347, transcript variant X2
kelch like family member 26, transcript variant X4
kelch like family member 26, transcript variant X1
kelch like family member 26, transcript variant X2
kelch like family member 26, transcript variant X3
cytokine receptor like factor 1, transcript variant X3
cytokine receptor-like factor 1 isoform X3
cytokine receptor like factor 1, transcript variant X5
cytokine receptor like factor 1, transcript variant X4
cytokine receptor-like factor 1 isoform X4
cytokine receptor-like factor 1 isoform X5
cytokine receptor like factor 1, transcript variant X2
cytokine receptor like factor 1, transcript variant X1
cytokine receptor-like factor 1 isoform X1
cytokine receptor-like factor 1 isoform X2
required for excision 1-B domain-containing protein
ubiquitin A-52 residue ribosomal protein fusion product 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
ubiquitin A-52 residue ribosomal protein fusion product 1
FK506 binding protein 8; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
FK506 binding protein 8, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP8 isoform X1
FK506 binding protein 8, transcript variant X2
FK506 binding protein 8, transcript variant X4
FK506 binding protein 8, transcript variant X3
peptidyl-prolyl cis-trans isomerase FKBP8 isoform X2
peptidyl-prolyl cis-trans isomerase FKBP8 isoform X3
peptidyl-prolyl cis-trans isomerase FKBP8
elongation factor for RNA polymerase II; Derived by automated computational analysis using gene prediction method: BestRefSeq.
similar to RNA sequence, mRNA (same species):RefSeq:NM_001012847.2
microRNA mir-12258; Derived by automated computational analysis using gene prediction method: BestRefSeq.
inositol-3-phosphate synthase 1, transcript variant X3
inositol-3-phosphate synthase 1, transcript variant X4
inositol-3-phosphate synthase 1, transcript variant X1
inositol-3-phosphate synthase 1, transcript variant X2
inositol-3-phosphate synthase 1 isoform X1
leucine rich repeat containing 25, transcript variant X1
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like isoform X1
pyroglutamyl-peptidase I, transcript variant X2
pyroglutamyl-peptidase I, transcript variant X3
pyroglutamyl-peptidase I, transcript variant X1
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm4
JunD proto-oncogene, AP-1 transcription factor subunit; Derived by automated computational analysis using gene prediction method: BestRefSeq.
JunD proto-oncogene, AP-1 transcription factor subunit
propagated from UniProtKB/Swiss-Prot (P27921.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
propagated from UniProtKB/Swiss-Prot (P27921.1); Region: Basic motif. /evidence=ECO:0000255|PROSITE-ProRule:PRU00978
propagated from UniProtKB/Swiss-Prot (P27921.1); Region: Leucine-zipper. /evidence=ECO:0000255|PROSITE-ProRule:PRU00978
proline-rich receptor-like protein kinase PERK2, transcript variant X1
proline-rich receptor-like protein kinase PERK2, transcript variant X2
proline-rich receptor-like protein kinase PERK2, transcript variant X3
uncharacterized LOC729966 homolog isoform X1
uncharacterized LOC729966 homolog isoform X2
uncharacterized LOC729966 homolog isoform X3
phosphodiesterase 4C, transcript variant X3
phosphodiesterase 4C, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X3
phosphodiesterase 4C, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X2
phosphodiesterase 4C, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1
RAB3A, member RAS oncogene family, transcript variant X2
RAB3A, member RAS oncogene family, transcript variant X1
MPV17 mitochondrial inner membrane protein like 2, transcript variant X1
MPV17 mitochondrial inner membrane protein like 2, transcript variant X2
gamma-interferon-inducible lysosomal thiol reductase isoform X1
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X1
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X3
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X2
phosphoinositide-3-kinase regulatory subunit 2, transcript variant X4
phosphatidylinositol 3-kinase regulatory subunit beta
microtubule associated serine/threonine kinase 3, transcript variant X3
microtubule associated serine/threonine kinase 3, transcript variant X1
microtubule associated serine/threonine kinase 3, transcript variant X2
microtubule associated serine/threonine kinase 3, transcript variant X4
microtubule-associated serine/threonine-protein kinase 3 isoform X3
microtubule-associated serine/threonine-protein kinase 3 isoform X1
microtubule-associated serine/threonine-protein kinase 3 isoform X2
microtubule-associated serine/threonine-protein kinase 3 isoform X4
interleukin 12 receptor subunit beta 1, transcript variant X1
interleukin 12 receptor subunit beta 1, transcript variant X2
interleukin 12 receptor subunit beta 1, transcript variant X3
interleukin-12 receptor subunit beta-1 isoform X1
interleukin-12 receptor subunit beta-1 isoform X2
interleukin-12 receptor subunit beta-1 isoform X3
arrestin domain containing 2, transcript variant X2
arrestin domain containing 2, transcript variant X1
arrestin domain-containing protein 2 isoform X2
arrestin domain-containing protein 2 isoform X1
chromosome 19 open reading frame 45, transcript variant X1
chromosome 19 open reading frame 45, transcript variant X4
chromosome 19 open reading frame 45, transcript variant X3
chromosome 19 open reading frame 45, transcript variant X2
chromosome 19 open reading frame 45, transcript variant X5
peroxisomal biogenesis factor 11 gamma; Derived by automated computational analysis using gene prediction method: BestRefSeq.
peroxisomal biogenesis factor 11 gamma, transcript variant 1
peroxisomal biogenesis factor 11 gamma, transcript variant 2
peroxisomal membrane protein 11C isoform 1
peroxisomal membrane protein 11C isoform 2
ectoderm-neural cortex protein 1-like, transcript variant X1
ectoderm-neural cortex protein 1-like, transcript variant X2
Rho guanine nucleotide exchange factor 18, transcript variant X6
Rho guanine nucleotide exchange factor 18, transcript variant X3
Rho guanine nucleotide exchange factor 18, transcript variant X5
Rho guanine nucleotide exchange factor 18, transcript variant X4
Rho guanine nucleotide exchange factor 18, transcript variant X2
Rho guanine nucleotide exchange factor 18, transcript variant X1
Rho guanine nucleotide exchange factor 18, transcript variant X8
Rho guanine nucleotide exchange factor 18, transcript variant X7
rho guanine nucleotide exchange factor 18 isoform X3
rho guanine nucleotide exchange factor 18 isoform X5
rho guanine nucleotide exchange factor 18 isoform X4
rho guanine nucleotide exchange factor 18 isoform X2
rho guanine nucleotide exchange factor 18 isoform X1
rho guanine nucleotide exchange factor 18 isoform X6
rho guanine nucleotide exchange factor 18 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments
unconventional SNARE in the ER 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
myosin IXB; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
HAUS augmin like complex subunit 8; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
HAUS augmin like complex subunit 8, transcript variant X1
HAUS augmin like complex subunit 8, transcript variant X2
HAUS augmin like complex subunit 8, transcript variant X3
HAUS augmin like complex subunit 8, transcript variant X4
HAUS augmin-like complex subunit 8 isoform X1
HAUS augmin-like complex subunit 8 isoform X2
HAUS augmin-like complex subunit 8 isoform X3
HAUS augmin-like complex subunit 8 isoform X4
HAUS augmin like complex subunit 8, transcript variant X7
HAUS augmin like complex subunit 8, transcript variant X8
HAUS augmin like complex subunit 8, transcript variant X5
HAUS augmin like complex subunit 8, transcript variant X6
HAUS augmin-like complex subunit 8 isoform X5
HAUS augmin-like complex subunit 8 isoform X6
HAUS augmin-like complex subunit 8 isoform X7
HAUS augmin-like complex subunit 8 isoform X8
C3 and PZP like, alpha-2-macroglobulin domain containing 8, transcript variant X1
C3 and PZP like, alpha-2-macroglobulin domain containing 8, transcript variant X3
C3 and PZP like, alpha-2-macroglobulin domain containing 8, transcript variant X2
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X1
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X3
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 isoform X2
SIN3 transcription regulator family member B
uncharacterized LOC121107759; Derived by automated computational analysis using gene prediction method: BestRefSeq.
NACHT and WE repeat domain containing 1 pseudogene; Derived by automated computational analysis using gene prediction method: Curated Genomic.
transmembrane protein 38A; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
transmembrane protein 38A, transcript variant X1
trimeric intracellular cation channel type A
propagated from UniProtKB/Swiss-Prot (Q5ZK43.1); transmembrane region
propagated from UniProtKB/Swiss-Prot (Q5ZK43.1); Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite
trimeric intracellular cation channel type A isoform X1
microRNA 6693; Derived by automated computational analysis using gene prediction method: BestRefSeq.
small integral membrane protein 7; Derived by automated computational analysis using gene prediction method: BestRefSeq.
mediator complex subunit 26, transcript variant X2
mediator of RNA polymerase II transcription subunit 26 isoform X2
mediator complex subunit 26, transcript variant X3
mediator complex subunit 26, transcript variant X1
mediator of RNA polymerase II transcription subunit 26 isoform X1
mediator of RNA polymerase II transcription subunit 26 isoform X3
calcium homeostasis endoplasmic reticulum protein; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
calcium homeostasis endoplasmic reticulum protein, transcript variant X1
calcium homeostasis endoplasmic reticulum protein
calcium homeostasis endoplasmic reticulum protein isoform X1
uncharacterized protein C19orf44 homolog isoform X2
uncharacterized protein C19orf44 homolog isoform X1
calreticulin 3; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X1
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X9
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X2
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X3
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X4
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X5
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X6
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X7
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X8
epidermal growth factor receptor substrate 15-like 1 isoform X4
epidermal growth factor receptor substrate 15-like 1 isoform X5
epidermal growth factor receptor substrate 15-like 1 isoform X7
epidermal growth factor receptor substrate 15-like 1 isoform X8
epidermal growth factor receptor substrate 15-like 1 isoform X1
epidermal growth factor receptor substrate 15-like 1 isoform X2
epidermal growth factor receptor substrate 15-like 1 isoform X3
epidermal growth factor receptor substrate 15-like 1 isoform X9
epidermal growth factor receptor substrate 15-like 1 isoform X6
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X11
epidermal growth factor receptor pathway substrate 15 like 1, transcript variant X10
epidermal growth factor receptor substrate 15-like 1 isoform X10
Kruppel like factor 2; Derived by automated computational analysis using gene prediction method: BestRefSeq.
adaptor related protein complex 1 mu 1 subunit; Derived by automated computational analysis using gene prediction method: BestRefSeq.
adaptor related protein complex 1 mu 1 subunit
family with sequence similarity 32 member A
calcium and integrin binding family member 3, transcript variant X1
calcium and integrin binding family member 3, transcript variant X2
calcium and integrin-binding family member 3 isoform X1
calcium and integrin-binding family member 3 isoform X2
RAB8A, member RAS oncogene family; Derived by automated computational analysis using gene prediction method: BestRefSeq.
Ras-related protein Rab-8A. /id=PRO_0000260749
propagated from UniProtKB/Swiss-Prot (Q5F470.1)
propagated from UniProtKB/Swiss-Prot (Q5F470.1); Region: Effector region. /evidence=ECO:0000250
Cysteine methyl ester. /evidence=ECO:0000255; propagated from UniProtKB/Swiss-Prot (Q5F470.1); methylation site
uncharacterized LOC107055376, transcript variant X2
uncharacterized LOC107055376, transcript variant X1
uncharacterized LOC107055376, transcript variant X4
uncharacterized LOC107055376, transcript variant X5
uncharacterized LOC107055376, transcript variant X3
uncharacterized LOC107055376, transcript variant X6
uncharacterized LOC107055376, transcript variant X7
protein tyrosine phosphatase, receptor type S; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
protein tyrosine phosphatase, receptor type S, transcript variant X4
protein tyrosine phosphatase, receptor type S, transcript variant X3
protein tyrosine phosphatase, receptor type S, transcript variant 1
protein tyrosine phosphatase, receptor type S, transcript variant 2
protein tyrosine phosphatase, receptor type S, transcript variant X5
protein tyrosine phosphatase, receptor type S, transcript variant X2
protein tyrosine phosphatase, receptor type S, transcript variant X10
protein tyrosine phosphatase, receptor type S, transcript variant X1
protein tyrosine phosphatase, receptor type S, transcript variant X12
protein tyrosine phosphatase, receptor type S, transcript variant X6
protein tyrosine phosphatase, receptor type S, transcript variant X13
protein tyrosine phosphatase, receptor type S, transcript variant X9
protein tyrosine phosphatase, receptor type S, transcript variant X19
protein tyrosine phosphatase, receptor type S, transcript variant X24
protein tyrosine phosphatase, receptor type S, transcript variant X7
protein tyrosine phosphatase, receptor type S, transcript variant X20
protein tyrosine phosphatase, receptor type S, transcript variant X8
protein tyrosine phosphatase, receptor type S, transcript variant X22
protein tyrosine phosphatase, receptor type S, transcript variant X11
protein tyrosine phosphatase, receptor type S, transcript variant X15
protein tyrosine phosphatase, receptor type S, transcript variant X14
protein tyrosine phosphatase, receptor type S, transcript variant X17
protein tyrosine phosphatase, receptor type S, transcript variant X16
protein tyrosine phosphatase, receptor type S, transcript variant X18
protein tyrosine phosphatase, receptor type S, transcript variant X21
protein tyrosine phosphatase, receptor type S, transcript variant X23
receptor-type tyrosine-protein phosphatase S isoform X1
receptor-type tyrosine-protein phosphatase S isoform X7
receptor-type tyrosine-protein phosphatase S isoform X2
receptor-type tyrosine-protein phosphatase S isoform X8
receptor-type tyrosine-protein phosphatase S isoform X5
receptor-type tyrosine-protein phosphatase S isoform X14
receptor-type tyrosine-protein phosphatase S isoform X19
receptor-type tyrosine-protein phosphatase S isoform X3
receptor-type tyrosine-protein phosphatase S isoform X15
receptor-type tyrosine-protein phosphatase S isoform X4
receptor-type tyrosine-protein phosphatase S isoform 1 precursor
receptor-type tyrosine-protein phosphatase S isoform X17
receptor-type tyrosine-protein phosphatase S isoform X6
receptor-type tyrosine-protein phosphatase S isoform X10
receptor-type tyrosine-protein phosphatase S isoform X9
receptor-type tyrosine-protein phosphatase S isoform X12
receptor-type tyrosine-protein phosphatase S isoform X11
receptor-type tyrosine-protein phosphatase S isoform X13
receptor-type tyrosine-protein phosphatase S isoform X16
receptor-type tyrosine-protein phosphatase S isoform 2 precursor
propagated from UniProtKB/Swiss-Prot (F1NWE3.3); Region: Important for binding to glycosaminoglycan chains. /evidence=ECO:0000269|PubMed:11865065
N-linked (GlcNAc...) asparagine. /evidence=ECO:0000255|PROSITE-ProRule:PRU00498; propagated from UniProtKB/Swiss-Prot (F1NWE3.3); glycosylation site
propagated from UniProtKB/Swiss-Prot (F1NWE3.3); transmembrane region
receptor-type tyrosine-protein phosphatase S isoform X18
microRNA 6666; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC107055377, transcript variant X2
uncharacterized LOC107055377, transcript variant X1
uncharacterized LOC107055377, transcript variant X3
uncharacterized LOC107055377, transcript variant X4
uncharacterized protein LOC107055377 isoform X2
uncharacterized protein LOC107055377 isoform X1
lysine demethylase 4B, transcript variant X5
lysine demethylase 4B, transcript variant X3
lysine demethylase 4B, transcript variant X2
lysine demethylase 4B, transcript variant X1
lysine demethylase 4B, transcript variant X4
lysine-specific demethylase 4B isoform X5
lysine-specific demethylase 4B isoform X3
lysine-specific demethylase 4B isoform X4
lysine-specific demethylase 4B isoform X2
lysine-specific demethylase 4B isoform X1
uncharacterized LOC124417447, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin like with PHD and ring finger domains 1, transcript variant X4
ubiquitin like with PHD and ring finger domains 1, transcript variant X3
ubiquitin like with PHD and ring finger domains 1, transcript variant X2
ubiquitin like with PHD and ring finger domains 1, transcript variant X1
E3 ubiquitin-protein ligase UHRF1 isoform X2
E3 ubiquitin-protein ligase UHRF1 isoform X1
E3 ubiquitin-protein ligase UHRF1 isoform X3
toll like receptor adaptor molecule 1; Derived by automated computational analysis using gene prediction method: BestRefSeq.
TIR domain-containing adapter molecule 1
uncharacterized LOC121107764, transcript variant X2
microRNA 7-3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
uncharacterized LOC121107764, transcript variant X1
uncharacterized LOC107055381, transcript variant X2
uncharacterized LOC107055381, transcript variant X1
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
dipeptidyl peptidase 9, transcript variant X3
dipeptidyl peptidase 9, transcript variant X1
dipeptidyl peptidase 9, transcript variant X4
dipeptidyl peptidase 9, transcript variant X2
dipeptidyl peptidase 9, transcript variant X5
cathepsin L1-like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
cathepsin L1-like, transcript variant X1
isoform 3 precursor is encoded by transcript variant 3; Derived by automated computational analysis using gene prediction method: BestRefSeq.
myeloid derived growth factor; Derived by automated computational analysis using gene prediction method: BestRefSeq.
TNF alpha induced protein 8 like 1; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
TNF alpha induced protein 8 like 1, transcript variant X2
TNF alpha induced protein 8 like 1, transcript variant X1
tumor necrosis factor alpha-induced protein 8-like protein 1
tumor necrosis factor alpha-induced protein 8-like protein 1 isoform X1
uncharacterized LOC112530392, transcript variant X2
uncharacterized LOC112530392, transcript variant X1